Defunct Company
Total Trials
3
As Lead Sponsor
0
As Collaborator
Total Enrollment
249
NCT00600067
A VI-0521 Study to Evaluate the Long-term Safety and Efficacy in Type 2 Diabetic Adults
Phase: Phase 2
Role: Collaborator
Start: Jan 31, 2008
Completion: Nov 30, 2008
NCT00737633
Open-Label Study to Evaluate the Long-Term Safety and Efficacy of VI-0521 in Type 2 Diabetic Adults
Start: Aug 31, 2008
Completion: Jun 30, 2009
NCT00768209
A Study to Evaluate the Pharmacokinetics of VI-0521 in Subjects With Hepatic Impairment
Phase: Phase 1
Start: Oct 31, 2008
Completion: Jul 31, 2009